The role of cellular phosphatidylinositol 5-phosphate (PtdIns5P), as a signalling molecule or as a substrate for the production of small, compartmentalized pools of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P 2 ], may be dependent on cell type and subcellular localization. PtdIns5P levels are primarily regulated by the PtdIns5P 4-kinases (type II PIP kinases or PIP4Ks), and we have investigated the expression and localization in the brain of the least-studied PIP4K isoform, PIP4K␥. In situ hybridization and immunohistochemistry, using antisense oligonucleotide probes and a PIP4K␥-specific antibody, revealed that this isoform has a restricted CNS expression profile. The use of antibodies to different cell markers showed that this expression is limited The regulation of PtdIns(4,5)P 2 levels in the brain has been associated with numerous diseases, such as cancer, bipolar disorder, and channelopathies (for reviews see Endersby and
MATERIALS AND METHODS PIP4K␥ cloning and expression
The PIP5K2C gene was amplified from a whole human brain marathon-ready cDNA library (Clontech, Mountain View, CA) and cloned into the plasmid expression vectors pET-32a (Novagen, Madison, WI) and pEGFP-C1 (Clontech) as previously described (Clarke et al., 2008) . Full-length recombinant PIP4K␥ was obtained by enterokinase cleavage of protein purified by TALON metal affinity resin (Clontech) from cell culture lysates of Escherichia coli BL21(DE3)pLysS transformed with the bacterial expression construct.
Endotoxin-free pEGFP-C1 plasmid constructs, purified from bacterial clones (Qiagen purification kit, Huntsville, AL), were used for eukaryotic expression. HeLa cells, maintained in DMEM (Gibco, Paisley, United Kingdom) supplemented with 10% fetal bovine serum, 50 U/ml penicillin, and 50 g/ml streptomycin were transiently transfected for 24 hours using TransFectin reagent (Bio-Rad, Hercules, CA), following the manufacturer's protocol.
Tissue preparation
Animal care was in accordance with institutional and national guidelines, and all procedures were performed in accordance with Home Office guidelines, Animals (Scientific Procedures) Act of 1986 under Home Office Project licence 80/1747. Samples were collected from P1, P7, P14, P21, P28, and adult male CD1 mice. Tissues used for cDNA library construction and Western blotting lysates were collected post-mortem from six animals and immediately frozen on dry ice. For imaging experiments, brains were removed from three mice that had been terminally anesthetized intraperitoneally with sodium pentobarbital and perfused transcardially with phosphate-buffered saline followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4. After cryoprotection in 0.1 M phosphate buffer with 30% sucrose, brains were stored at -80°C. 
RT-PCR and in situ hybridization

Primary antibody characterization
PIP4K␥ was detected using a custom rabbit polyclonal antibody raised against a synthetic peptide representing amino acids 333-352 from the variable region of murine PIP4K␥. This antibody specifically stains purified recombinant PIP4K␥ protein and a 47-kDa molecular weight band from mouse brain by Western blotting, and this signal is abolished in blotting and immunochemistry experiments by preincubation with excess antigenic peptide (this study; Clarke et al., 2008 
Western blotting
Whole mouse brains were dissected under a binocular microscope and separated into nine regions, and protein lysates were prepared in RIPA buffer (150 mM sodium chloride, 50 mM Tris pH7.4, 1 mM EDTA, 1% Triton X-100, 1% deoxycholic acid, 0.1% SDS) with 10 mM tetrasodium pyrophosphate, 10 mM sodium fluoride, 17.5 mM ␤-glycerophosphate, and 100 l/ml protease inhibitor cocktail (Sigma-Aldrich; catalog No. P8340) as previously described (Clarke et al., 2008 
Microscopy and figure preparation
Light microscopy was performed with an Axioskop II microscope (Carl Zeiss GmbH, Munich, Germany), and images were saved as TIF format in AxioVision software (Carl Zeiss GmbH). Confocal microscopy was carried out by sequential scanning with a Leica TCS SP5 laser scanning confocal microscope running LAS AF software (Leica Microsystems Ltd., Milton Keynes, United Kingdom). Images were tinted and output as TIF files from Image J.
Autoradiographic images developed from in situ hybridization and electrophoresis gels were scanned and output as TIF files by using a Hewlett-Packard scanjet 8200 scanner and VueScan software (Hamrick Software, Pheonix, AZ). Figures were prepared for publication in Adobe Photoshop (Adobe Systems, San Jose, CA), adjusting image brightness and contrast only.
RESULTS
PIP5K2C has an expression profile in mouse brain
Previous studies have suggested that PIP5K2 isoforms are differentially transcribed according to tissue ( (Fig. 1 ). Among the tissues tested, PIP5K2A mRNA levels were comparatively higher in mouse spleen, PIP5K2B levels were higher in muscle, and PIP5K2C was the predominant isoform in kidney (this study; Clarke et al., 2008). However, mRNA for each isoform was also detected, at different levels, in brain (Fig. 1) . Tissue analysis by in situ hybridization with two different PIP5K2C probes confirmed that transcription of this isoform was upregulated in discrete regions of the brain, compared with a control tissue (Fig. 2) . Silver grain labeling of PIP5K2C mRNA in brain suggested that expression was confined to cells on the boundary of the molecular and granular layers of the cerebellum and in large cell bodies in the hippocampus (CA1-CA3), cerebral cortex, and olfactory bulb (Fig. 2) .
Endogenous PIP4K␥ is expressed in specific brain regions
With a polyclonal peptide antibody specific to the variable region of PIP4K␥ ( Fig. 3; Clarke et al., 2008) , our results indicated that this PIP4K isoform is differentially expressed within the mouse brain. Crude dissection of mouse brain tissue and Western blotting of the protein lysates allowed direct comparison of PIP4K␥ levels in these regions. Equivalent samples (by total protein loading) were standardized to the loading control (␣-tubulin), and quantification indicated that PIP4K␥ levels were higher in the cerebral cortex, hippocampus, spinal cord, and olfactory bulb, with significant expression also seen in the cerebellum and brainstem (Fig. 4) . Tissue lysates from these regions were further investigated to resolve multiple PIP4K␥-immunoreactive bands. Western blotting of samples with comparative PIP4K␥ levels indicated the presence of three distinct bands at 47, 48, and 49 kDa (Fig.  5) . The two lower molecular weight bands were present in all of the six regions, whereas the 49-kDa band was equivalent in the cerebellum and hippocampus; significantly reduced in the cortex, brainstem, and spinal cord; and completely absent from the olfactory bulb (Fig. 5) . Treatment of samples with phosphatase removed the 48-and 49-kDa bands, suggesting that these were phosphorylated forms of PIP4K␥ (Fig. 5) (Fig. 7A-C) , and this expression did not extend into the corpus callosum or cingulum region or into the caudate-putamen. High levels of expression were seen in the hippocampal formation, primarily in the stratum pyramidale and extending into the stratum radiatum of CA1-CA3, and were excluded from the dentate gyrus (Fig. 7E-G) . Within the cerebellar cortex, PIP4K␥ was observed in large cell bodies of the Purkinje layer, extending into the dendritic trees of these cells, but was absent from the granular layer (Fig. 7M-O) . PIP4K␥ expression was excluded from the majority of the medulla (Fig. 8E-G ) but was present in the dorsal horn of the spinal cord (Fig. 8A-C) trigeminal nucleus and tract (data not shown). Positive signal was also observed throughout the cervical, thoracic, and lumber spinal cord regions (data not shown) and large neuronal cell bodies in the dorsal root ganglia (see Fig. 12C ). Lower level expression was observed in the pontine gray, and the remainder of the pons, midbrain, thalamus, and hypothalamus were negative (Figs. 7I-K, 8I-K) . In the olfactory bulb, PIP4K␥ expression was seen in cells extending from the mitral cell layer to the olfactory nerve layer and into the anterior olfactory nucleus but excluded from the granular cell layer (Fig. 8M-O) .
Expression of PIP4K␥ is restricted to specific neurons
Further characterization of PIP4K␥-positive cells in the adult mouse brain indicated that this phosphoinositide kinase is preferentially expressed in cells that are costained with neuronal cell markers (Figs. 9 -11; Supp. Info. Figs. 1, 2) . Use of a fluorescent counterstain to identify neurons by abundance of Nissl substance (Quinn et al., 1995) colocalized PIP4K␥ to these cells in each region studied (Figs. 9C,F,O,R,  10C,L, 11C) , and this was confirmed by colocalization with the neuronal class III ␤-tubulin marker TUJ1 (Supp Info. Fig. 1) . PIP4K␥ was not expressed in granule cells in the cerebellum (Fig. 10C ) or in the dentate gyrus (Fig. 9O) . Costaining with an antibody to the glial cell marker GFAP (Figs. 9I,U, 10F,O) suggested that the PIP4K␥ signal was excluded from these cells. Furthermore, staining of pyramidal cell cultures (derived from hippocampus) for endogenous PIP4K␥ indicated that these neurons were PIP4K␥ positive (Fig. 11I) , whereas primary cell cultures of granule cells (derived from cerebellum) showed little endogenous signal (Fig. 11L) . Within the cerebral cortex, hippocampus, and olfactory bulb, the subset of neurons expressing PIP4K␥ was excluded from the subpopulations expressing the calcium-binding protein calbindin D-28k (Figs. 9L,X, 10R) , and parvalbumin (Supp. Info. Fig. 2C,F,L) , a calcium-binding marker of GABAergic interneurons, which is predominantly expressed by chandelier and basket cells in the cortex (Hendry et al., 1989 ). In the cerebellum, both of these markers were present in PIP4K␥-positive Purkinje cells ( Fig. 10I; Supp Info. Fig. 2I ), and, within the spinal cord, the population of PIP4K␥-positive neurons included subpopulations positive for both calbindin D-28k (Fig. 11F ) and parvalbumin (Supp. Info. Fig. 2O ).
PIP4K␥ has a distinct subcellular compartmentalization
Confocal microscopy at high resolution and costaining with a range of markers for different subcellular compartments allowed the identification of a distinct vesicular location for PIP4K␥. In all of the neurons observed expressing PIP4K␥, endogenous signal was present in the cell body and dendritic projections but was mostly excluded from the nucleus (Fig.  12) . Subcellular localization was cytoplasmic and partially perinuclear, with clear, punctate staining (Fig. 12A-C) , similar to that observed in kidney cells (Clarke et al., 2008) . Costaining of endogenous PIP4K␥ in brain tissue with markers for the endoplasmic reticulum and Golgi apparatus suggested that the vesicular PIP4K␥ compartment might partially colocalize with one of these structures (Fig. 12F,I,L) .
To investigate this potential association in more detail, HeLa cells were transiently transfected with constructs expressing PIP4K␥ fused to the GFP reporter protein, because very low endogenous levels of PIP4K␥ were observed in neuronal cell lines such as SH-SY5Y (data not shown). Cells were permeabilized to reduce the levels of free cytosolic protein produced by overexpression, as judged by the reduction of overexpressed control GFP levels (Supp. Info. Fig. 3 ). Treat- did not affect the staining of other cellular compartment markers. PIP4K␥ was not seen to colocalize with the endoplasmic reticulum resident Grp78 (Supp. Info. Fig. 5C ), in accordance with previous observations (Clarke et al., 2008) , or the -ergic Golgi vesicle docking protein p115 (Fig. 13C) . Partial colocalization after digitonin treatment was observed with the Golgi markers GM130 (Fig. 13F) , 58K, mannosidase II, and golgin 160 (Supp. Info. Fig. 4 ) and the endosomal markers EEA1 and mannose-6-phosphate receptor (Fig. 13I,L) , but not the lysosomal markers LAMP-1 and LAMP-2 or the peroxisomal marker catalase (Supp. Info. Fig. 5F,I,L) . However, the PIP4K␥ protein remaining after stronger detergent treatment did not completely localize to any of these compartments (Fig.  13O ,R,U,X; Supp. Info. Fig. 6 ).
PIP4K␥ expression during postnatal development
Examination of similar brain sections in a murine postnatal developmental series indicated that the onset of PIP4K␥ expression from neurons was between postnatal days 7 and 14 (Fig. 14) . Establishment of Purkinje cells and defined dendritic trees in the Purkinje layer of the cerebellum was apparent at P14, and staining for endogenous PIP4K␥ indicated that this enzyme was also expressed by Purkinje cells at this time. Spaces in the Purkinje cell layer may be due to naturally occurring neuronal cell death (Madalosso et al., 2005) . Similar results were observed for PIP4K␥ expression in hippocampal pyramidal cells and the mitral cell layer of the olfactory bulb (Fig. 14) .
DISCUSSION
Here we have investigated the expression of the PIP4K isoforms in the murine brain, with specific reference to PIP4K␥. We have further characterized the restricted localization of this PIP4K in different regions of the brain, identified the neuronal cells expressing the protein, and suggested a subcellular compartmentalization that has implications for the physiological function of this isoform.
PIP4K expression and neuronal localization
Gene expression profiles for the PIP5K2s, collated as MIAME-compliant microarray data on the EMBL ArrayExpress Warehouse database (Parkinson et al., 2007) , support the observations that there are tissue-specific differences in isoform abundance (Clarke et al., 2008) . PIP4K␣ is the most abundant isoform in spleen and blood components, such as platelets ( 
PIP4K␥ subcellular distribution and neuronal function
The expression of PIP4K␥ in a neuronal subpopulation from P14 to adult would suggest that this enzyme might have a specific involvement with neuronal function. Our observation that PIP4K␥ is present in large neuronal cell bodies, as well as throughout their dendritic projections, would suggest a central rather than a peripheral role. Our results also suggest that, as with specialized cells in the mammalian nephron (Clarke et al., 2008) , PIP4K␥ is localized to a vesicular cytoplasmic compartment that is partially coincident with components of the endomembrane system. The absence of a recognized signal peptide within the PIP4K␥ sequence suggests that this protein would not be directly targeted to the ER or plasma membrane, in accordance with our colocalization studies, and hence may be associated with the external surface of a trafficking compartment ( nase such as PIP4K, and has a role in membrane trafficking (Lecompte et al., 2008) . PIP4K␥ has also been associated with actin remodelling during endocytic transport (Pelkmans et al., 2005) , suggesting that modification of the PtdIns5P signal or synthesis of PtdIns(4,5)P 2 in a specific compartment might have a role in this process. Recombinant PIP4K␥ has no detectable intrinsic kinase activity, although enzyme recovered from a mammalian expression system is seen to be active (Itoh et al., 1998) . Our previous study suggested that this activity could also be attributable to the ability of PIP4K␥ to associate with other, more active PIP4K isoforms (Clarke et al., 2008) and that PIP4K␥ might function to recruit this activity to a specific cellular compartment. It should also be noted that there have been several recent reports of the regulation of various membrane channels by phosphoinositides (for reviews see Gamper and Shapiro, 2007; Suh and Hille, 2005) , which could be coincident with delivery of the channel complexes to the plasma membrane. Although there is as yet no direct evidence for the involvement of PIP4K␥ in these processes, it remains an intriguing possibility that the PIP4Ks are involved in neuronal function via one of these mechanisms.
The restricted expression of PIP4K␥ in the CNS may be significant within the context of the specialized function of different neurons. It remains to be seen whether the role of phosphoinositide signalling involving this kinase is a common feature to the population of neurons that express it or whether there are different, neuron-specific functions of PtdIns5P, or localized pools of PtdIns(4,5)P 2 , in these cells.
